CONTINENTAL ADVISORS LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1277779 Park City, UT

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$3,583,886

-$369,622 QoQ

Shares Held

28,367

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.24%

of 13F equity value

Holder Rank

#665

of 2,266 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2024

CallValue

$2,096,000

CallShares

25,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CONTINENTAL ADVISORS LLC holds $18,125,438 across 3 Drug Manufacturers - General names. GILD ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	415,438	$10,003,747
2	BMY	Bristol Myers Squibb Co	78,754	$4,537,805
3	GILD	Gilead Sciences, Inc. This page	28,367	$3,583,886

All Filings in GILD

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,583,886	28,367	0.0%	Shares	Sole	2026-07-27
2026-03-31	$3,953,508	28,367	-13.7%	Shares	Sole	2026-05-15
2025-12-31	$4,034,095	32,867	-4.4%	Shares	Sole	2026-02-12
2025-09-30	$3,814,737	34,367	-4.2%	Shares	Sole	2025-11-03
2025-06-30	$3,976,574	35,867	-20.1%	Shares	Sole	2025-08-19
2025-03-31	$5,027,347	44,867	-20.4%	Shares	Sole	2025-05-16
2024-12-31	$5,206,619	56,367	-6.6%	Shares	Sole	2025-02-14
2024-09-30	$5,061,169	60,367	-19.9%	Shares	Sole	2024-11-14
2024-09-30	$2,096,000	25,000	-50.8%	Call	Sole	2024-11-14
2024-06-30	$5,170,929	75,367	+17.9%	Shares	Sole	2024-08-14
2024-06-30	$3,485,388	50,800	+130.9%	Call	Sole	2024-08-14
2024-03-31	$4,680,894	63,903	-14.7%	Shares	Sole	2024-05-15
2024-03-31	$1,611,500	22,000	-26.7%	Call	Sole	2024-05-15
2023-12-31	$6,067,892	74,903	-8.5%	Shares	Sole	2024-02-14
2023-09-30	$6,137,810	81,903	0.0%	Shares	Sole	2023-11-14
2023-06-30	$6,312,264	81,903	-16.8%	Shares	Sole	2023-08-14
2023-03-31	$8,164,496	98,403	+34.1%	Shares	Sole	2023-05-15
2022-12-31	$6,301,647	73,403	-12.5%	Shares	Sole	2023-02-14
2022-12-31	$1,717,000	20,000	—	Put	Sole	2023-02-14
2022-12-31	$2,575,500	30,000	-33.3%	Call	Sole	2023-02-14
2022-09-30	$2,776,050	45,000	-18.2%	Call	Sole	2022-11-14
2022-09-30	$5,178,073	83,937	-4.5%	Shares	Sole	2022-11-14
2022-06-30	$3,399,550	55,000	-31.2%	Call	Sole	2022-08-15
2022-06-30	$5,435,385	87,937	0.0%	Shares	Sole	2022-08-15
2022-03-31	$5,227,854	87,937	+3.5%	Shares	Sole	2022-05-16
2022-03-31	$4,756,000	80,000	+60.0%	Call	Sole	2022-05-16
2021-12-31	$3,630,500	50,000	0.0%	Call	Sole	2022-02-14
2021-12-31	$6,167,275	84,937	-15.0%	Shares	Sole	2022-02-14
2021-09-30	$6,980,599	99,937	-19.4%	Shares	Sole	2021-11-15
2021-09-30	$3,492,500	50,000	+400.0%	Call	Sole	2021-11-15
2021-06-30	$8,534,301	123,937	-2.4%	Shares	Sole	2021-08-16
2021-03-31	$8,203,938	126,937	+41.9%	Shares	Sole	2021-05-17
2021-03-31	$646,300	10,000	-75.0%	Call	Sole	2021-05-17
2020-12-31	$2,330,400	40,000	+53.8%	Call	Sole	2021-02-16
2020-12-31	$5,210,599	89,437	+48.0%	Shares	Sole	2021-02-16
2020-09-30	$1,642,940	26,000	+160.0%	Call	Sole	2020-11-16
2020-09-30	$3,819,014	60,437	+42.4%	Shares	Sole	2020-11-16
2020-06-30	$3,265,102	42,437	+13.4%	Shares	Sole	2020-08-14
2020-06-30	$769,400	10,000	—	Call	Sole	2020-08-14
2020-03-31	$2,798,790	37,437	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.